• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.

作者信息

Melo J V, Catovsky D, Galton D A

出版信息

Blood Cells. 1987;12(2):339-53.

PMID:3476167
Abstract

A series of 300 cases of chronic B-cell leukemia was studied in relation to clinical and laboratory features, and three groups were identified on the basis of the percentage of circulating prolymphocytes (%PROL): typical CLL less than or equal to 10% PROL, 174 cases; PLL greater than 55% PROL, 42 cases; and an intermediate group CLL/PL (11%-55% PROL), 84 cases. Some features of the CLL/PL group resemble those of PLL, such as a disproportionate splenomegaly in relation to the degree of lymphnode involvement. However, membrane markers suggested a closer affinity of CLL/PL with CLL [high percentage of M rosettes, expression of the P67 (T1) antigen, and low reactivity with the McAb FMC7], although high-density SmIg was found in one-third of CLL/PL, as well as in the majority of the PLL cases. Cells volume measurements demonstrated that the prolymphocytes of both PLL and CLL/PL are significantly larger than the homogeneous population of small lymphocytes of typical CLL. Followup studies of the PB picture in CLL and CLL/PL showed that the majority of patients maintain a relatively stable percentage of PROL, but a progressive prolymphocytoid transformation to a PLL-like disease may occur in some cases. On univariate analysis of survival, seven features of disease had a high prognostic values for the whole group of patients: %PROL, absolute number of PROL (ABS PROL), WBC, spleen size, M rosettes, SmIg intensity, and age. However, only ABS PROL (greater than 15 X 10(9)/l) and spleen size (greater than 8 cm) were shown to be independent prognostic features on a multivariate regression analysis. The median survival time of patients with PLL (3 years) was significantly shorter than the median of 8 years for patients with CLL. Within the heterogeneous CLL/PL group, patients with ABS PROL greater than 15 X 10(9)/l (two-thirds) had a median survival time as bad as for PLL patients, whereas the median has not been reached for those with ABS PROL less than 15 X 10(9)/l.

摘要

相似文献

1
Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
Blood Cells. 1987;12(2):339-53.
2
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.慢性淋巴细胞白血病与幼淋巴细胞白血病的关系。I. 300例患者的临床和实验室特征及一个中间组的特征描述
Br J Haematol. 1986 Jun;63(2):377-87.
3
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features.慢性淋巴细胞白血病与幼淋巴细胞白血病的关系。IV. 生存及预后特征分析。
Br J Haematol. 1987 Jan;65(1):23-9. doi: 10.1111/j.1365-2141.1987.tb06130.x.
4
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.慢性淋巴细胞白血病与幼淋巴细胞白血病的关系。II. “幼淋巴细胞样”转化的演变模式。
Br J Haematol. 1986 Sep;64(1):77-86. doi: 10.1111/j.1365-2141.1986.tb07575.x.
5
[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].[慢性淋巴细胞增殖性疾病白血病类型的临床和实验室预后参数]
Acta Med Croatica. 2008 Oct;62(4):351-64.
6
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.氟达拉滨+泼尼松一线治疗晚期慢性淋巴细胞白血病患者淋巴细胞形态的预后意义
Haematologica. 2002 Jun;87(6):602-8.
7
Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.慢性淋巴细胞白血病中CD23及其配体CD21的定量表达
Haematologica. 2000 Nov;85(11):1140-5.
8
[B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].[B 细胞慢性淋巴细胞白血病/幼淋巴细胞白血病(CLL/PL)——病例报告]
Rinsho Ketsueki. 1990 Nov;31(11):1840-4.
9
[Chronic lymphocytic leukemia in Japan].[日本的慢性淋巴细胞白血病]
Rinsho Ketsueki. 1990 May;31(5):554-63.
10
Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.呈现出类似慢性淋巴细胞白血病及变异型的B细胞淋巴瘤的白血病期。
Mod Pathol. 2002 Nov;15(11):1111-20. doi: 10.1097/01.MP.0000031710.32235.24.

引用本文的文献

1
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases.套细胞区(中间型)淋巴瘤的白血病期:11例病例特征分析
J Clin Pathol. 1989 Sep;42(9):962-72. doi: 10.1136/jcp.42.9.962.